| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 322 |
| 1 | ADALIMUMAB | 254 |
| 2 | PREDNISONE | 164 |
| 3 | METHOTREXATE SODIUM | 143 |
| 4 | AMBRISENTAN | 138 |
| 5 | NIRMATRELVIR AND RITONAVIR | 135 |
| 6 | METHOTREXATE | 126 |
| 7 | ALBUTEROL SULFATE | 123 |
| 8 | ERGOCALCIFEROL | 122 |
| 9 | NATALIZUMAB | 103 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 1 | 0.0357 |
| 1 | DENOSUMAB-BMWO | 1 | 0.0303 |
| 2 | GADOPICLENOL | 2 | 0.0072 |
| 3 | INFLIXIMAB-DYYB | 20 | 0.0058 |
| 4 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| 5 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 1 | 0.0044 |
| 6 | SIBEPRENLIMAB | 3 | 0.0044 |
| 7 | ERGOCALCIFEROL | 122 | 0.0041 |
| 8 | ENALAPRILAT | 1 | 0.0039 |
| 9 | RESLIZUMAB | 2 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 362 |
| 1 | Corticosteroid [EPC] | 301 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 266 |
| 3 | Endothelin Receptor Antagonist [EPC] | 176 |
| 4 | Vitamin C [EPC] | 144 |
| 5 | Benzodiazepine [EPC] | 137 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 125 |
| 7 | Provitamin D2 Compound [EPC] | 122 |
| 8 | Integrin Receptor Antagonist [EPC] | 109 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 107 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 34 | 0.0494 |
| 1 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 2 | Provitamin D2 Compound [EPC] | 122 | 0.0041 |
| 3 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 4 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 5 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 6 | Interleukin-17A Antagonist [EPC] | 50 | 0.0013 |
| 7 | Integrin Receptor Antagonist [EPC] | 109 | 0.0013 |
| 8 | PCSK9 Inhibitor [EPC] | 32 | 0.0012 |
| 9 | Nitrofuran Antibacterial [EPC] | 20 | 0.0011 |